Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

X4 Pharmaceuticals (XFOR) Interest Coverage Ratio (2018 - 2025)

X4 Pharmaceuticals (XFOR) has disclosed Interest Coverage Ratio for 8 consecutive years, with 12.19 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Interest Coverage Ratio rose 14.72% year-over-year to 12.19, compared with a TTM value of 11.0 through Sep 2025, down 254.71%, and an annual FY2024 reading of 4.15, up 77.69% over the prior year.
  • Interest Coverage Ratio was 12.19 for Q3 2025 at X4 Pharmaceuticals, down from 11.75 in the prior quarter.
  • Across five years, Interest Coverage Ratio topped out at 32.68 in Q2 2024 and bottomed at 31.41 in Q4 2021.
  • Average Interest Coverage Ratio over 5 years is 16.07, with a median of 19.9 recorded in 2024.
  • The sharpest move saw Interest Coverage Ratio surged 245.37% in 2024, then tumbled 135.97% in 2025.
  • Year by year, Interest Coverage Ratio stood at 31.41 in 2021, then grew by 28.82% to 22.36 in 2022, then surged by 40.24% to 13.36 in 2023, then decreased by 16.02% to 15.5 in 2024, then grew by 21.37% to 12.19 in 2025.
  • Business Quant data shows Interest Coverage Ratio for XFOR at 12.19 in Q3 2025, 11.75 in Q2 2025, and 4.29 in Q1 2025.